COMMON STOCK PURCHASE WARRANT BRAINSTORM CELL THERAPEUTICS INC.Brainstorm Cell Therapeutics Inc. • June 7th, 2018 • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date (as set forth above) and on or prior to the close of business on December 31, 2020 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • June 7th, 2018 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances)
This Warrant Exercise Agreement (this “Agreement”), dated as of June 6, 2018, is by and among Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), and the undersigned holder of a Common Stock Purchase Warrant (the “Existing Warrant”) issued by the Company on January 8, 2015 (the “Holder”).
LEAK-OUT AGREEMENTLeak-Out Agreement • June 7th, 2018 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances)
This agreement (the “Leak-Out Agreement”) is being delivered to you in connection with an understanding by and among Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), and the person or persons named on the signature pages hereto (collectively, the “Holder”).
